已收盤 12-19 16:00:00 美东时间
-2.400
-1.70%
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
XPO shares are trading higher after the company announced that its Executive Ch...
12-15 21:56
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
12-09 10:32
今日重点评级关注:Guggenheim:维持Cybin Inc. Common Shares"买入"评级,目标价从39美元升至48美元;HC Wainwright & Co.:维持Capricor Therapeutics"买入"评级,目标价从24美元升至60美元
12-04 09:38
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
12-03 09:58
U.S. stocks found their footing Tuesday, posting a modest rebound after Monday's pullback as the global bond sell-off sparked by the Bank of Japan finally cooled.
12-03 01:55
B of A Securities analyst Ken Hoexter maintains XPO (NYSE:XPO) with a Buy and raises the price target from $151 to $158.
12-02 21:56
FedEx (FDX) is set to split in two by spinning off its FedEx Freight division, creating a new standalone public company. The separation is scheduled to be completed on June 1, following a long 18-mo...
11-15 20:00
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
XPO Q3 2025 earnings beat forecasts, reporting $2.11B revenue, $1.07 adjusted EPS, and improved North American LTL performance despite shipment declines.
10-30 21:23